tiprankstipranks
Trending News
More News >
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
US Market

Elicio Therapeutics (ELTX) Income Statement

Compare
215 Followers

Elicio Therapeutics Income Statement

Last quarter (Q3 2025), Elicio Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Elicio Therapeutics's net income was $-10.08M. See Elicio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 28.31M$ 2.88M
Gross Profit
$ -1.18M$ -1.17M$ -1.06M$ 27.08M$ 1.06M
Operating Expenses
$ 43.81M$ 34.58M$ 22.68M$ 66.39M$ 56.34M
Depreciation and Amortization
$ 1.18M$ 1.17M$ 1.06M$ 801.00K$ 628.00K
EBITDA
$ -50.27M$ -32.97M$ -23.55M$ -51.92M$ -70.63M
Operating Income
$ -44.99M$ -35.74M$ -23.73M$ -39.31M$ -55.27M
Other Income/Expenses
$ -6.91M$ 550.00K$ -4.47M$ -15.27M$ -24.83M
Pretax Income
$ -51.90M$ -35.20M$ -28.21M$ -54.57M$ -80.11M
Net Income
$ -51.90M$ -35.20M$ -28.21M$ -26.40M$ -80.11M
Per Share Metrics
Basic EPS
$ -4.25$ -6.96$ -9.10$ -19.32$ -1.93
Diluted EPS
$ -4.25$ -6.96$ -9.10$ -19.32$ -1.93
Weighted Average Shares Outstanding
12.20M 5.06M 3.10M 3.20M 8.15M
Weighted Average Shares Outstanding (Diluted)
12.20M 5.06M 3.10M 3.20M 8.15M
Currency in USD

Elicio Therapeutics Earnings and Revenue History